| Bioactivity | ACAT-IN-10 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example 197. ACAT-IN-10 weakly inhibits NF-κB mediated transcription[1]. |
| Name | ACAT-IN-10 |
| CAS | 454203-40-8 |
| Formula | C35H56N4O5S |
| Molar Mass | 644.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Joseph Anthony Cornicelli, et al. Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders. EP1236468A1. |
ACAT-IN-10
CAS: 454203-40-8 F: C35H56N4O5S W: 644.91
ACAT-IN-10 is an acyl-Coenzyme A:cholesterol acyltransferase (ACAT) inhibitor extracted from patent EP1236468A1, example
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.